Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuji Kurashige is active.

Publication


Featured researches published by Shuji Kurashige.


Chemical & Pharmaceutical Bulletin | 1987

Isoxazole Derivatives as Centrally Acting Muscle Relaxants. III. Synthesis and Activity of Conformationally Restricted Analogs

Tochiro Tatee; Kazuhisa Narita; Shuji Kurashige; Shinji Ito; Hiroshi Miyazaki; Hiroshi Yamanaka; Michinao Mizugaki; Takao Sakamoto; Hideomi Fukuda


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo Agents. I. Structure-Activity Relationships of 2-(2-Aminoethyl) pyridines

Akira Shiozawa; Yuhichiro Ichikawa; Chikara Komuro; Genichi Idzu; Michio Ishikawa; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Archive | 1987

Derivatives of an aminoketone

Akira Shiozawa; Michio Ishikawa; Giichi Izumi; Katsuhiko Sakitama; Kazuhisa Narita; Shuji Kurashige; Takeji Sakasai; Kazuo Ohtsuki; Hideo Sugimura; Hirotaka Yamamoto


Archive | 1986

New derivatives of an aminoketone

Akira Shiozawa; Michio Ishikawa; Giichi Izumi; Katsuhiko Sakitama; Kazuhisa Narita; Shuji Kurashige


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo Agents. III. Synthesis of 5, 6, 7, 8-Tetrahydro-1, 6-naphthyridine Methyl Homologs

Akira Shiozawa; Yuhichiro Ichikawa; Chikara Komuro; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.

Akira Shiozawa; Yuh-Ichiro Ichikawa; Michio Ishikawa; Yoshiya Kogo; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Archive | 1987

An optically active propanone derivative and process for producing the same and use thereof

Akira Shiozawa; Michio Ishikawa; Hideo Sugimura; Kazuhisa Narita; Hirotaka Yamamoto; Takeji Sakasai; Kazuo Ohtsuki; Shuji Kurashige


Chemical & Pharmaceutical Bulletin | 1984

Antivertigo Agents. IV. Synthesis and Antivertigo Activity of 6-[ω-(4-Aryl-1-piperazinyl) alkyl]-5,6,7,8-tetrahydro-1,6-naphthyridines

Akira Shiozawa; Yuhichiro Ichikawa; Chikara Komuro; Michio Ishikawa; Yasuhiko Furuta; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto


Organic Process Research & Development | 2005

Development of a large-scale synthesis of sulphostin, a dipeptidyl peptidase IV inhibitor

Masatoshi Abe; Masashi Nagai; Keiichiro Yamamoto; Hiroko Yamazaki; Ichiro Koga; Yoshitaka Satoh; Yasuhiko Muraoka; Shuji Kurashige; Yuh-Ichiro Ichikawa


Chemical & Pharmaceutical Bulletin | 1985

Antivertigo Agents. V. Quantitative Structure-Activity Relationships of 6-[2-(4-Aryl-1-piperazinyl) ethyl]-5, 6, 7, 8-tetrahydro-1, 6-naphthyridines

Akira Shiozawa; Yoshiya Kogo; Yuhichiro Ichikawa; Chikara Komuro; Michio Ishikawa; Shuji Kurashige; Hiroshi Miyazaki; Hiroshi Yamanaka; Takao Sakamoto

Collaboration


Dive into the Shuji Kurashige's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge